首页> 外文期刊>International Journal of Research in Medical Sciences >Study of prevalence of secondary hyperparathyroidism in chronic renal failure in hadoti region
【24h】

Study of prevalence of secondary hyperparathyroidism in chronic renal failure in hadoti region

机译:Hadoti地区慢性肾功能衰竭中继发性甲状旁腺功能亢进的研究

获取原文
           

摘要

Background: Secondary hyperparathyroidism is known and early complication of chronic renal failure patients. Aim of this study was to assess the prevalence of secondary hyperparathyroidism and correlation between serum parathyroid hormone level with biochemical parameters in renal failure patients in tertiary care hospital in Kota, Rajasthan. Methods: A cross sectional observational study was carried out in 50 patients who had creatinine clearance of 30ml/min/1.73m 2 or less for greater than 6 weeks attended the OPD of department of General Medicine, New Medical College hospital, Kota, Rajasthan from May 2018 to November 2018. Investigations like complete blood count, renal function test, urine routine microscopy and USG abdomen with serum parathyroid hormone, serum phosphorus, serum calcium levels were done. Serum parathyroid hormone level was done by calorimetric method. Results: The prevalence of secondary hyperparathyroidism in our study was 72%. In hyperparathyroidism patient’s serum calcium level was low and the difference was highly significant (p0.001). There is negative correlation between S.PTH and S. calcium level (r=-0.536). Mean serum calcium level in our study is 1.6mmol/l. In hyperparathyroidism patient’s serum phosphate level was high and the difference was highly significant (p0.001). There was positive correlation between S.PTH and S.PO4 level (r=0.402). Mean serum phosphorus level in our study is 5.7 mg/dl. Prevalence of hyperparathyroidism was high among CRF patients with normal BP than hypertensive patients and with normal sugar than diabetics but the difference in proportion was not significant (p=0.87, p=0.98 respectively). 90% patients were on haemodialysis while 10% patients were on conservative management. Conclusions: Early detection of secondary hyperparathyroidism in chronic renal failure patients can reduce its complications like bone fracture and cardiovascular complications.
机译:背景:慢性肾功能衰竭患者的次级甲状旁腺功能亢进是已知的和早期并发症。本研究的目的是评估叔川贾斯坦高等护理医院肾功能衰竭患者血清甲状旁腺功能亢进和血清甲状旁腺激素水平之间的相关性的患病率。方法:在50名患者中进行了横截面观察研究,肌酐清除30ml / min / 1.73米2或更低,超过6周,参加了普通医学,新医院医院,Kota,Rajasthan的OPD 2018年5月至2018年11月。采用完整血统计数,肾功能试验,尿常规显微镜和血清甲状旁腺激素,血清磷,血清钙水平的肾功能试验,尿常规显微镜和USG腹部等调查。血清甲状旁腺激素水平是通过量热法完成的。结果:我们研究中继发性甲状旁腺功能亢进的患病率为72%。在甲状旁腺功能亢进患者的血清钙水平较低,差异非常显着(P <0.001)。 S.Pth和S.钙水平之间存在负相关(R = -0.536)。我们研究中的平均血清钙水平为1.6mmol / L.在甲状旁腺功能亢进患者的血清磷酸盐水平高,差异非常显着(P <0.001)。 S.Pth和S.PO4级别之间存在正相关(r = 0.402)。我们研究中的平均血清磷水平为5.7mg / dL。患有正常BP的CRF患者的患者患者患病率高于高血压患者,甘蔗酸常见,但比例的差异不显着(P = 0.87,P = 0.98)。 90%的患者在血液透析中,而10%的患者是保守管理。结论:早期检测继发性慢性肾功能衰竭患者中的​​继发性甲状旁腺功能亢进,可以降低骨折和心血管并发症等并发症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号